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Marmin or (7-(6’,7’-dihydroxygeranyl-oxy)coumarin is an active 
compound isolated from Aegle marmelos Correa. The study aimed to 
investigate the effects of marmin on the histamine release from rat mast 
cell. The study was performed by using rat basophilic leukemia (RBL-
2H3) cell line and rat peritoneal mast cells (RPMCs). The histamine 
release from these cells was determined by using HPLC fluorometric 
method. In this study, marmin succeeded to inhibit the histamine release 
from RBL-2H3 cell line induced by DNP24-BSA, thapsigargin or 
ionomycin. In addition, marmin suppressed 45Ca2+ influx on RBL-2H3 
cell line induced by thapsigargin. Marmin also succeeded to inhibit the 
histamine release from RPMCs induced by thapsigargin. However, 
marmin showed weak inhibitory effects on the histamine release from 
RPMCs induced by compound 48/80, PMA or ionomycin. Based on the 
results, the inhibitory effect of marmin on the histamine release from 
mast cells high depends on the type of mast cell and also involves 
mechanisms related to intracellular Ca2+ signaling events by blocking 
Ca2+ influx into mast cells.  







Mast cell is a mediator involved in many 
different acute and chronic inflammatory 
processes. The cells act in both delayed and 
immediate hypersensitivity reactions [1,2]. 
Allergy (type I hypersensitivity reaction) can be 
triggered in present of allergen such as grass 
pollen, product from dust mites, foodstuffs or 
some drugs. First step of allergy stimulation is 
production of antibodies of the IgE type, and then 
bind to FcεRI receptors on membrane surface of 
mast cell and eosinophils. Subsequently, a series  
 
of intracellular signaling events is generated, and 
then trigger granule exocytosis, which releases 
allergy mediators from mast cells such as 
histamine, eicosanoids and cytokines. Histamine 
has most important role in the inflammatory 
reactions and immune responses. Therefore, these 
mediators induce location-dependent effects such 
as hay fever in the nose, the initial phase of 
asthma in the bronchial tree, urticaria in the skin 
or gastrointestinal tractus irritations [3,4]. 
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Many antiallergy drugs have been developed 
from several sources including from natural 
products. Natural products have served as a major 
source of drugs for centuries, and about half of 
the pharmaceuticals in use today are derived from 
natural products [5]. Over 50% of the best-selling 
pharmaceuticals in use are derived from natural 
products [6]. Natural products contain diverse 
chemical compounds as sources of therapeutics. 
Recent progress to discover drugs from natural 
product sources has resulted in compounds that 
are being developed to treat some diseases [7]. 
Therefore it is urgent and promising to discover 
new potential antiallergy drug isolated from 
natural products. 
 
Aegle marmelos Correa is a species belongs to 
Rutaceae family. They originate from and grow 
widely in some areas of the Southeast and South 
Asia countries. This plant has been widely used 
as an ancient and modern traditional medicine for 
treatment of various disorders in Indonesia, 
Malaysia and its surrounding areas. Aegle 
marmelos Correa has been reported having 
several pharmacological activities such as 
antiproliferative, anti-inflammatory, antipyretic, 
analgesic, antioxidant, antifungal, antiviral, 
hypoglycemic, and antidiabetes [8-14]. Several 
compounds of this plant have been isolated and 
evaluated for their pharmacological effects [15-
17]. It is necessary to focus and develop the 
compounds to be effective drugs.  
 
In the present study, we investigated the in vitro 
antiallergic effect of marmin, a coumarine 
compound isolated from Aegle marmelos Correa. 
Marmin (7-(6’,7’-dihydroxygeranyl-oxy) 
coumarin (Fig. 1) was isolated from the bark and 
fresh root extracts of Aegle marmelos Correa 
[15,16,18]. In the study, we used two kinds of 
mast cell, rat basophilic leukemia (RBL-2H3) 
cells and rat peritoneal mast cells (RPMCs). 
DNP24-BSA, thapsigargin, ionomycin, compound 
48/80, and PMA were used as inducers for 
histamine release from mast cell. The result of 
these studies may provide useful information for 
further discovering pharmacologically traditional 
plants isolated-active compounds for treatment 
































Figure 1. Chemical structure of marmin. 
 
Materials and Methods 
Preparation of marmin 
Marmin or (7-(6’,7’-dihydroxygeranyl-oxy) 
coumarin was isolated from Aegle marmelos 
Correa. The chemical structures of the 
compounds are shown in Fig.1. The plant was 
collected from area around Yogyakarta, 
Indonesia [18]. Aegle marmelos was identified by 
a botanist at Department of Pharmaceutical 
Biology, Faculty of Pharmacy, Universitas 
Gadjah Mada, Indonesia. The voucher specimen 
was deposited in herbarium of the department.   
 
In brief, dried ground powder of bark and fresh 
root were extracted successively with petroleum 
ether, chloroform and methanol. Chloroform 
extract of both were chromatographed over silica 
gel, and selected fractions were further 
chromatographed using mini column to yield 
several fractions. Selected fractions were 
combined and concentrated, and the solid 
obtained was recrystrallized to yield marmin. 
Methanol extract of dried ground powder of bark 
or petroleum ether extract of dried ground 
powder of fresh root were separated using 
vacuum column chromatography with gradient 
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elution to yield several fractions. Selected 
fractions were combined and evaporated, then 
separated by using gravity column 
chomatography to provide marmin. 
 
Materials 
The histamine release inducers used in the study 
were ionomycin (Calbio-Chem), thapsigargin, 
compound 48/80, and phorbol myristate acetate 
(Sigma, Chemical).  Dinitrophenylated bovine 
serum albumin (DNP24-BSA) as an antigen and 
monoclonal IgE against DNP24-BSA purified 
from supernatant in IgE producing hybridoma, 
were produced in our laboratory. Eagle’s 
minimum essential medium (MEM) and 
antibiotics (combination of penicillin G sodium 
and streptomycin sulfate) were purchased from 
Gibco (Grand Island, New York). Fetal calf 
serum was obtained from JRH Biosciences 
(Kansas, USA), piperazine-1,4-bis(2-
ethanesulfonic acid) (PIPES) and bovine serum 
albumin (BSA) were purchased from Dojindo 
(Kumamoto, Japan), and o-phthalaldehyde was 
purchased from Wako Pure Chemical Co. 
(Osaka, Japan). PIPES buffer consisted of NaCl 
(119 mM), KCl (5mM), PIPES (25 mM), glucose 
(5.6 mM), MgCl2 (0.4 mM), CaCl2 (1 mM), 
NaOH (40 mM), and BSA (0.1 %) and was 
adjusted to pH 7.20.  
 
Culture of RBL-2H3 cells 
RBL-2H3 cells were cultured in MEM containing 
15% fetal calf serum (FCS) and antibiotics 
(penicillin and streptomycin) in a flask in a 
humidified atmosphere (5% CO2) at 37°C [19]. 
The cells were seeded into 24-well culture plates 
at a density of 5 x 105 cells/0.4 ml per each well, 
and then incubated overnight at 37°C. In DNP24-
BSA experiments, the cells were sensitized with 
0.5 μg/ml of monoclonal IgE. On the second day, 
the medium was removed, and the cells were 
washed twice with 500 μl of PIPES buffer, and 
preincubated for 10 min at 37°C after addition of 
180 μl PIPES buffer either without (as a negative 
control) or with the drug. After 10 min 
preincubation, 20 μl of stimulant (200 ng/mL 
DNP24-BSA, 5 μM thapsigargin, or 10 μM 
ionomycin) were added to each well and the plate 
was incubated at 37°C for 30 min.  
 
Isolation of RPMCs 
Male Wistar rats (250-300 g, 3-4 months) were 
used. The animal experiments were conducted 
according to the guidelines of the Animal Care 
Committee of the Ehime University, and all 
experimental protocols had been approved by this 
Committee. Rats were killed by decapitation and 
exsanguination. RPMCs were isolated by 
injection of  25 mL phosphate buffered saline 
(PBS)  pH 7.4 containing 5 IU/ml heparin and 
10% BSA into the peritoneal cavity and the 
abdomen was massaged for about 120 s. 
Afterwards, the peritoneal cavity was opened 
carefully, and the fluid containing mast cells were 
collected. The collected mast cells were 
centrifuged at 1,000 rpm for 5 min at room 
temperature and then resuspended in 2 ml PBS 
buffer containing 10% BSA. Peritoneal mast cells 
were separated from the other components 
(macrophages and lymphocytes) by layering on 4 
ml of 38% BSA, and centrifuging at 2,000 rpm 
for 20 minutes at 4°C. After the upper layer 
containing other components was aspirated and 
discarded, the remaining cell pellet was washed 
with 6 ml PBS buffer and resuspended in 1 ml of 
PIPES buffer. Mast cell preparations were about 
95% pure as assessed by toluidine blue staining. 
 
One hundred twenty μl of RPMC suspension 
(2x104 cells/ml) was preincubated for 10 min at 
37°C after addition of 60 μl PIPES buffer either 
without (as a negative control)  or with drugs at a 
range of concentrations (0.1 – 100 μM). After 10 
min preincubation, 20 μl of stimulant (100 μM 
compound 48/80, 5 μM thapsigargin, 10 μM 
ionomycin, or a combination of 100 nM PMA 
and 1 μM ionomycin) was added to each well and 
the plates were incubated at 37°C for 30 min.  
 
Assay of histamine release 
Level of histamine release was measured by 
HPLC-fluorometry as described previously study 
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centrifuged at 3,000 rpm for 5 min and 50 μl of 
the supernatant was mixed with 250 μl of 3% 
perchloric acid containing 5mM Na2-EDTA. 
After addition of 30 μl of 2 M KOH/1 M KH2PO4 
and centrifugation at 10,000 x g for 15 min at 
4°C , 50 μl of the supernatant was injected 
directly onto a column packed with TSKgel SP-
2SW cation exchanger (Tosoh, Tokyo). For 
measuring the total histamine content in cells, 
350 μl of PIPES buffer was added to 6 wells and 
the cells were then sonicated. Fifty microlitres 
cell homogenate was used for the histamine assay 
described above. Histamine was eluted with 0.25 
M potassium phosphate at a flow rate of 0.6 
ml/min, and post-labeled with o-phthalaldehyde 
under alkaline conditions and detected using a 
F1080 Fluorometer (Hitachi, Tokyo) at excitation 
and emission wavelengths of 360 and 450 nm, 
respectively.  The values were expressed as a 
percentage of net histamine release. 
 
Uptake of 45Ca2+ 
RBL-2H3 cells in a 24 well-plate were incubated 
for overnight at at 37°C. Then, the cells were 
washed twice with 500 μl of  PIPES buffer and 
then preincubated for 10 min at 37°C in 180 μl 
PIPES buffer either without (as a negative 
control) or with the drug.  After preincubation, 
PIPES buffer containing 45Ca2+ (5μCi/mL) and 
Ca2+ uptake stimulant (thapsigargin) was added 
into each well, and the plate was incubated at 
37°C for 15 min. After this time,  the reaction 
was stopped by washing with ice-cold Ca2+-free 
buffer containing 100 μM La3+. The cells were 
lysed with 0.3 ml of 0.1% Triton X, and 100 μL 
of the solution was combined with 10 ml of 
scintillation cocktail for radioactivity counting. 
The values were expressed as the percentage of 
maximum uptake in the absence of inhibitor 
compounds. 
 
Analysis of data 
The percentage of net histamine release was 
calculated according to the following equation: 
[Histamine concentration (in supernatant of cells 
stimulated) – histamine concentration (in the 
supernatant of unstimulated cells)] / [Total 
histamine content – histamine concentration (in 
the supernatant of unstimulated cells)] X 100.    
 
Whereas, the percentage of inhibition of 
histamine release or Ca2+ influx was calculated 
according to the following equation: [histamine 
release without drug (negative control) – 
histamine release with drug treatment] / 
histamine release without drug (negative control) 
X 100.  
 
Statistical analysis 
All data were expressed as mean ± SEM. One-
way analysis of variance (ANOVA) followed by 
the least significant difference (LSD) test were 
used for statistical analyses. P-values less than 
0.05 were considered significant. 
 
Results 
Effects on Histamine Release from RBL-2H3 
Cells  
In present study, DNP24-BSA (20 ng/mL) 
stimulated histamine release from RBL-2H3 cells 
by 30% (Fig. 1a). The histamine release was 
markedly inhibited by marmin in a concentration-
dependent manner. At maximum dose (100 μM) 
marmin inhibited the histamine release from 
RBL-2H3 by 62.06 ± 1.95%. 
 
Thapsigargin and ionomycin, which act on Ca2+ 
influx and intracellular calcium pathways [21-22] 
stimulated histamine release by 37.2±0.4%; and 
33.2±1.9%, respectively (Fig. 1b and 1c). 
Marmin suppressed the histamine release 
successfully when induced by 0.5 μM 
thapsigargin or 1 μM ionomycin. Marmin 
showed a significant effect at the dose of 10 μM 
in thapsigargin experiment, and 30 μM in 
ionomycin experiment. At the maximum dose 
(100 μM), marmin suppressed the histamine 
release about 60% in both experiments. Marmin 
effect was presumed to be related to intracellular 
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showed the IC50 values of the inhibitory effects of 
marmin on the histamine release from RBL-2H3 
cells induced by DNP-BSA, thapsigargin and 
ionomycin. These values represent potency of 






























































































Figure 2. Effect of marmin on histamine release from RBL-2H3 cells in the presence (solid bar) or absence (open bar) of 
histamine stimulants i.e. DNP-BSA 20 ng/mL (a), thapsigargin 0.5 μM (b), or ionomycin 1 μM (c). Data represent mean±SEM, 
and are three independent experiments. *Significant difference (P<0.05) compared to the negative control value. 
 
 
In the study, we also observed the possibility of 
induction of histamine release from RBL-2H3 
cells by marmin with a series of concentration (1-
100 μM), even though no histamine stimulant 
was added. The effect was considered significant 
if marmin caused spontaneous histamine release 
of more than 10 %. All concentrations of marmin 
showed low spontaneous histamine release, less 
than 10 % of the total histamine contained in 
RBL-2H3 Cells (Fig. 2). 
 
Effects on Histamine Release from RPMCs  
Compound 48/80, thapsigargin, ionomycin, and 
PMA were used for stimulating the histamine 
release rat peritoneal mast cells (RPMCs). The 
net histamine release from RPMCs affected by 
marmin in the presence or absence of histamine 
stimulants are shown in Fig. 3. Compound 48/80, 
acting directly on G proteins in mast cells [25-26] 
increased histamine release from RMPCs by 
more than 88.88±2.82 % of the total cellular 
content of histamine. In the study, marmin could 
not suppress the histamine release induced by 10 
μM compound 48/80. Marmin effect was 
presumed to be not related to signaling events in 
G proteins activation pathways.  
 
Thapsigargin (0.5 μM) and ionomycin (1 μM), 
which stimulate the Ca2+ signaling in mast cell, 
increased histamine release from RMPCs by 
57.38±1.66%; and 77.84±2.08%, respectively 
(Fig. 3b and 3c). Marmin showed weak inhibitory 
effects on the histamine release induced by 
ionomycine, and at high dose (100 μM) could 
suppress the histamine release weakly only 13% 
of the total histamine content. However, marmin 
still succeeded to deplete the histamine when 
thapsigargin used as a histamine stimulant. 
Marmin showed a gradual inhibitory effect, and 
then finally suppressed the histamine release until 
40 % at the highest dose. Nevertheless, this effect 





























































































































Figure 3. Effect of marmin on histamine release from rat peritoneal mast cells (RPMCs) in the presence (solid bar) or absence 
(open bar) of histamine stimulants i.e. compound 48/80 10 μM (a), thapsigargin 0.5 μM  (b), ionomycin 1 μM (c); or phorbol 
myristate acetate 10 nM-ionomycin 0.1 μM (d).Data represent mean±SEM, and are three independent experiments. *Significant 
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Inhibition of 45Ca2+ influx The combination of PMA (10 nM), a modulator 
of protein kinase C (PKC) [27-28], and low-dose 
ionomycin (0.1 μM)  increased histamine release 
by 89.23±2.62% in RPMCs (Fig. 3d). Marmin 
also did not success to deplete the histamine 
release from RPMCs. At highest dose only, 
marmin showed a significant inhibitory effect on 
the histamine release by 6.77±0.98%. The 
potency of marmin effect on the histamine release 
from RPMCs is shown in table 1. This value is 
expressed as IC50.  
Previously, marmin showed promising effects in 
RBL-2H3 when induced by histamine stimulant 
acting on Ca2+ signaling pathway such as 
thapsigargin and ionomycin. This study 
investigated the effect of marmin on intracellular 
Ca2+ signaling.  The study was conducted by 
direct measurement of radiolabelled Ca2+ uptake 
in RBL-2H3 cells after stimulation with 
thapsigargin (Fig. 4). In parallel with previous 
results, marmin inhibited intracellular 45Ca2+ 
incorporation concentration-dependently. 
Moreover, at highest dose (100 μM) marmin 
successfully suppress the Intracellular 
accumulation of 45Ca2+ by 75.94±4.15%. 
 
In absence of histamine stimulator, marmin did 
not show significant spontaneous histamine 
release in RMPCs. All concentrations of marmin 
showed low spontaneous histamine release, less 
than 10 % of the total histamine contained in 
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Figure 4. Inhibition of 45Ca2+ uptake by marmin isolated from Aegle marmelos Correa in thapsigargin-stimulated RBL-2H3 
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Table 1. The mean of IC50 of marmin effects on the histamine release from RBL-2H3 cells and RPMCs with several histamine 
release inducers. 
Histamine inducer IC50 (μM) % inhibition of histamine release at 100 μM 
1. RBL-2H3 cell lines 
           DNP-BSA 
      Thapsigargin 




62.06 ± 1.95 
68.70 ± 3.54 











39.35 ± 3.60 
10.32 ± 4.47 




Coumarin derivatives isolated from plants are 
considered potential to be developed as anti-
allergic agents. Compound 3,4- dimethyl-7 -[4     
-(p-chlorobenzyl) -pyperazine-1 -yl]                     
-propoxicoumarin. dihydrochloride was reported 
to possess an activity as a histamine receptor 
antagonist. The compound also inhibited antigen-
induced histamine release from sensitized human 
leucocytes, and inhibited the re-uptake of 
histamine by isolated human leukocytes [23]. 
Cnidicin and its related coumarins isolated from 
the root extract of Angelica koreana inhibited the 
degranulation process by inhibiting the β-
hexoaminidase release from RBL-2H3 cells [24]. 
Other coumarins, 7-methoxycoumarin and 7-
hydroxycoumarin also showed inhibitory effects 
on mediator release from RBL-2H3 cells. The 
study of structure-activity relationship among 
coumarine compounds indicated that oxigen-
containing moiety at the 7-position of coumarin 
structure has a main role for the inhibitory effect 
[25]. 
 
In the study, we evaluated the antiallergic effects 
of marmin, a coumarine isolated from Aegle 
marmelos Correa. Marmin was investigated for 
its effects on histamine release from rat mast cells 
induced by several histamine stimulants. Marmin 
was isolated from dried ground powder of bark 
and fresh root of Aegle marmelos Correa, then 
using petroleum ether, chloroform and methanol 
for extraction solvents. Marmin was provided 
after subsequent purification using 
chromatography methods and recrystallization 
[18].  
 
There are only few available literatures 
concerning the pharmacological activity of 
marmin. Takase et al. reported that marmin 
isolated from Aurantii fructus immaturus protect 
the gastric mucosal on the experimental acute 
gastric lesions by maintenance of the mucosal 
barrier integrity, inhibition on gastric motor 
activity, and prevent the effects of acetylcholine 
and histamine [26]. 
In the present study, marmin inhibited histamine 
release from RBL-2H3 cells induced by DNP24-
BSA, an specific antigen for monoclonal IgE 
antibody [27-28]. Its fact indicates that the 
compound might alter the effect of DNP24-BSA 
on mast cells by affecting its interaction with IgE 
on the mast cell surface or by altering 
intracellular signal transductions involved in mast 
cell degranulation. 
 
To evaluate the inhibitory effect of marmin 
involving intracelullar Ca2+ levels, thapsigargin 
and ionomycin were used for stimulate the 
release of histamine from mast cell. 
Thapsigargin, a sesquiterpene lactone isolated 
from the plant Thapsia garginica, is a Ca2+ 
signaling stimulant. Its target is the ATP-
dependent Ca2+ pump in the endoplasmic 
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cytosolic free calcium ion [21-22]. Ca2+ release 
from intracellular store plays a major role in the 
opening of cell membrane Ca2+ channels to cause 
Ca2+ influx in mast cells [4]. Ionomycin, a 
selective Ca2+ ionophore, also induces histamine 
release from mast cells by increasing in 
intracellular Ca2+ concentration, both through the 
release from intracellular Ca2+ pools 
(endoplasmic reticulum) and via Ca2+ influx [29]. 
In our study, marmin inhibit successfully the 
histamine release from RBL-2H3 cells induced 
by thapsigargin and ionomycin. These data were 
supported by the finding that marmin potently 
suppressed 45Ca2+ uptake from extracelullar side. 
RBL-2H3 cell is totally dependent on the influx 
of external Ca2+. Blockage of Ca2+ influx cause a 
rapid decline in intracellular Ca2+ concentration 
and then decrease the release of histamine from 
this cells [30]. Its fact indicates that the effect of 
marmin on the release of histamine involve 
alteration on the influx of external Ca2+.  
 
In RPMCs experiments, marmin inhibited the 
histamine release induced by thapsigargin, even 
though the effect was lower than this in RBL-
2H3 cells. Moreover, marmin showed low 
inhibitory effect when histamine stimulated by 
ionomycin. RMPCs still release low histamine in 
the absence of influx of external Ca2+ [31-32]. In 
this case, the intracellular Ca2+ pool has an 
important role in histamine secretion [33]. Figure 
4, marmin could suppress the influx of external 
Ca2+ the but not complete that still allow a few 
amount of Ca2+ from external side to trigger 
intracellular Ca2+ pool depletion. These findings 
indicate that marmin may inhibit intracellular 
Ca2+ from Ca2+ influx rather than from 
intracellular Ca2+ pool.  
 
In the study, marmin did not influence the 
histamine release from RPMCs induced by 
compound 48/80. Compound 48/80 is known to 
activate mast cell secretory processes by 
increasing the rate of GTP S binding to G-
proteins (Go/Gi mixture) [34,35]. Compound 
48/80 also stimulates histamine release from 
RPMCs in both the presence and absence of 
extracellular calcium [4]. Its fact indicates that 
the inhibitory effect of marmin is not related to 
signaling events in G protein activation pathway. 
 
PMA is a histamine secretagogue that activates 
PKC signaling event in mast cells [36,37]. PMA 
does not elicit histamine release to the same 
extent as other inducers of histamine release [38]. 
Since the activity of PKC in promoting granule 
exocytosis and inflammatory mediator release 
from mast cells is dependent on the intracellular 
Ca2+ concentration [39,40], a sub-effective dose 
of calcium ionophore is often used concomitantly 
with PMA to stimulate histamine release [41-43]. 
In RPMCs, marmin showed very low inhibitory 
effect on the histamine release induced by PMA 
and ionomycin in combination. It is suggested 
that this compound may did not alter the 
interaction between PKC and intracellular Ca2+ 
during granule exocytotic processes. 
 
As mentioned above that the mechanism of 
histamine release from mast cells involve several 
intracellular signaling pathways. In the study, 
marmin successfully influence the histamine 
release from mast cells when using DNP24-BSA, 
thapsigargin and ionomycin in RBL-2H3 cells 
since this cell is totally dependent on Ca2+ influx. 
It is supported that marmin also successfully 
inhibit the influx of external Ca2+. In the other 
hand, marmin did not influence or showed low 
inhibitory effects in RPMCs, a type of mast cell 
still release low histamine in absence of Ca2+ 
influx. Based on these facts, marmin is suggested 
to inhibit the histamine release from mast cell by 
blocking by blocking Ca2+ uptake. Nevertheless, 
further study is required to investigate the detail 
mechanism of marmin in mast cells. Moreover, 
the further in vivo study is very useful to provide 
information to further explain drug action.        
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